SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 6.14 |
| Enterprise Value ($M) | 2.19 |
| Book Value ($M) | -1.67 |
| Book Value / Share | -0.66 |
| Price / Book | -3.68 |
| NCAV ($M) | -1.67 |
| NCAV / Share | -0.66 |
| Price / NCAV | -3.68 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.33 |
| Return on Equity (ROE) | -2.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.72 |
| Current Ratio | 0.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.23 |
| Assets | 4.23 |
| Liabilities | 5.90 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -14.36 |
| Net Income | -13.16 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -12.90 |
| Cash from Investing | 12.89 |
| Cash from Financing | 2.98 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Cytovance Biologics Inc | 9.80 | -92.04 | |
| 13G/A | Bristol Investment Fund Ltd | 8.80 | -41.56 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 264 | 9,026 | 2.92 | |
| 4,342 | 22,167 | 19.59 | |
| 11,107 | 190,063 | 5.84 | |
| 1,085 | 8,572 | 12.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GNPX – Genprex, Inc. | GOVX – GeoVax Labs, Inc. |
| GRCE – Grace Therapeutics, Inc. | GYRE – Gyre Therapeutics, Inc. |
| HCWB – HCW Biologics Inc. |
Financial data and stock pages provided by
Fintel.io